Reprogramming the tumor microenvironment and T cells for ovarian cancer immunotherapy.

被引：0
|
作者：
Odunsi, Kunle [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
EFFICACY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA22
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] Heterogeneity of exhausted T cells in the tumor microenvironment is linked to patient survival following resection in hepatocellular carcinoma
    Liu, Fangming
    Liu, Weiren
    Sanin, David E.
    Jia, Guangshuai
    Tian, Mengxin
    Wang, Han
    Zhu, Bijun
    Lu, Yan
    Qiao, Tiankui
    Wang, Xiangdong
    Shi, Yinghong
    Wu, Duojiao
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [42] Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model
    Xu, Huan
    Hu, Mengying
    Liu, Mengrui
    An, Sai
    Guan, Kaiyun
    Wang, Menglin
    Li, Lei
    Zhang, Jing
    Li, Jun
    Huang, Leaf
    BIOMATERIALS, 2020, 235
  • [43] Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment
    Guo, Fengguang
    Das, Jugal K.
    Kobayashi, Koichi S.
    Qin, Qing-Ming
    Ficht, Thomas A.
    Alaniz, Robert C.
    Song, Jianxun
    De Figueiredo, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [44] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Han, Ethan Q.
    Li, Xiu-ling
    Wang, Chun-rong
    Li, Tian-fang
    Han, Shuang-yin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [45] Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment
    Dumont, Nancy
    Merrigan, Samantha
    Turpin, Jason
    Lavoie, Cynthia
    Papavasiliou, Vasilios
    Geretti, Elena
    Espelin, Christopher W.
    Luus, Lia
    Kamoun, Walid S.
    Ghasemi, Omid
    Sahagian, G. Gary
    Muller, William J.
    Hendriks, Bart S.
    Wickham, Thomas J.
    Drummond, Daryl C.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 17 : 71 - 81
  • [46] m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
    Liu, Fen
    Liu, Qingbin
    Li, Xianying
    Wang, Yufei
    Cao, Ruoyu
    Zhang, Shiyu
    Jiang, Shulong
    Wu, Jianlin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [47] Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development
    Jo, Yeonho
    Choi, Nakwon
    Kim, Kyobum
    Koo, Hyung-Jun
    Choi, Jonghoon
    Kim, Hong Nam
    THERANOSTICS, 2018, 8 (19): : 5259 - 5275
  • [48] Inflammation-Regulated Nanodrug Sensitizes Hepatocellular Carcinoma to Checkpoint Blockade Therapy by Reprogramming the Tumor Microenvironment
    Wang, TianCheng
    Lin, MinZhao
    Mao, JunJie
    Tian, LiRong
    Gan, HaiRun
    Hu, XinYan
    Yan, LeYe
    Long, HaoYu
    Cai, JianXun
    Zheng, XiaoDi
    Xiao, YuDong
    Li, Dan
    Shuai, XinTao
    Pang, PengFei
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (44) : 49542 - 49554
  • [49] In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy
    Li, Qiao
    Teitz-Tennenbaum, Seagal
    Donald, Elizabeth J.
    Li, Mu
    Chang, Alfred E.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (05) : 3195 - 3203
  • [50] Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer
    Liu, Xinyue
    Kong, Yan
    Qian, Youwen
    Guo, Haoyue
    Zhao, Lishu
    Wang, Hao
    Xu, Kandi
    Ye, Li
    Liu, Yujin
    Lu, Hui
    He, Yayi
    TRANSLATIONAL ONCOLOGY, 2024, 50
12345